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The aerial part of Thymelaea hirsuta (TH) is used as decoction in the treatment of different pathologies 
in folk medicine in Morocco. The present investigation was carried out to evaluate the potential of toxicity of 
an aqueous extract of TH and its hepatoprotective activity against CCl4-induced hepatic injury in rats. In the 
acute study, there were no signs of toxicity observed after oral administration of single dose of the extract (5 
g/kg body weight). In the sub-chronic dose study, (given by gavages (4 ml/kg) to Wistar rats daily at: 0.0 g/kg, 
0.5g/kg, 1 g/kg or 2 g/kg body weight for 4 weeks) no variation on biochemical parameters; serum glucose, 
creatinine and urea levels was observed compared to the control group. However, the serum levels of alanine 
aminotransferase (ALAT) and aspartate aminotransferase (ASAT) were markedly decreased (P < 0.05 and 
P<0.001 respectively) as compared to the controls. There were no significant differences in red blood cells 
count (p<0.05), in Hemoglobin and Hematocrit serum levels but a significant increase in white blood cells 
count (p<0.001) and in platelets (p< 0.05) for all doses tested. Histopathological examination of the liver, 
spleen and kidneys tissues at the end of the study showed normal architecture. The elevated serum enzymatic 
activities of ALAT and ASAT, due to carbon tetrachloride treatment (1 ml/kg CCl4 every 72 h during 15 days) 
were restored towards normalization by the plant extracts. The biochemical observations were supplemented 
with histopathological examination of liver sections. The results indicate that this plant possesses no toxicity 
effects but hepatoprotective properties.  
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Thymelaea hirsuta is a plant belonging 
to Thymeleaceae family commonly known as 
“Methnane” in Morocco. The  aerial  part  of  
this  plant  is  used  as  decoction  in  the  
treatment of diabetes. T.  hirsuta  has  been  
used  in  folk medicine  for  its 
antimelanogenesis  (Kawano et al., 2007; 




Villareal et al.,  2010),  and antioxidant  
(Djeridane et al., 2005) properties. It was 
shown that the aqueous extract of T. hirsuta 
possesses both hypoglycemic and antidiabetic 
effects in normoglycemic and streptozotocin-
induced diabetic rats (Bnouham et al., 2007, 
2010).  
The phytochemical compositions of 
different extracts of T. Hirsuta have been well 
studied (Djeridane et al., 2005; Douhou et al., 
2004). This plant contains polyphenols with 
substantial part of flavonoids, diterpens that 
can explain its different pharmacological 
activities. Two new daphnane diterpenoids, 
hirseins A and B isolated from the aerial parts 
of Thymelaea hirsuta were found to inhibit 
melanogenesis in B16 murine melanoma cells 
(Miyamae et al., 2009). 
Herbal medicine is gaining popularity in 
developing countries. Herbal remedies are 
often believed to be harmless because they are 
“natural,” and are commonly used for self 
medication without supervision. This increase 
in popularity and the scarcity of scientific 
studies on their safety and effective effect 
have raised concerns regarding toxicity and 
adverse effects of these remedies (Saad et al., 
2006). These products contain bioactive 
principles with the potential to cause adverse 
effects (Bent et al., 2004). 
Although its use is widespread, there is 
a lack of detailed toxicological information in 
the literature or in related cases of poisoning 
by Thymelaea hirsuta in Morocco (data of 
Anti-poison and pharmacovigilance Center of 
Morocco). Therefore, the aim of the present 
study was first to assess the toxicity of an 
aqueous extract of T. hirsuta on Wistar rats by 
the evaluation of biochemical and 
hematological parameters and histological 
studies and then to explore the potential of its 
in vivo hepatoprotective activity against CCl4-
induced hepatotoxicity. The carbon 
tetrachloride treatment was used extensively 
to investigate hepatoprotective activity on 
various experimental animals. It is 
biotransformed by Cytochrome P450 to active 
CCl3 radical, which further reacts with oxygen 
to form trichloromethylperoxyl radical 
(CCl3O2•) that bonds covalently to cellular 
macromolecules and causes peroxidative 
degradation of lipids membrane of the adipose 
tissue. This leads to the formation of lipid 
peroxides, which in turn yield products like 
MDA, which causes loss of integrity of cell 
membranes and damage to hepatic tissue 
(Thabrew et al., 1987). The hepatoprotective 
activity in vivo was studied on rat liver 
damage induced by CCL4.by monitoring 
biochemical parameters and histological 
changes.  
 
MATERIALS AND METHODS 
Animals 
Wistar rats weighing (220±20 g) of 
either sex were purchased from the animal 
house of the Department of Biology, Faculty 
of Sciences, Rabat, Morocco. They were kept 
in departmental animal house in well cross-
ventilated room at 25±2 °C, and relative 
humidity 44–56%, light and dark cycles of 10 
and 14 h, respectively, for 2 weeks before and 
during the experiments. Animals were 
provided with standard rodent pellet diet, 
water (the double distilled water) was allowed 
ad libitum. All the experiments were 
performed in the morning according to current 
guidelines for the care of the laboratory 
animals and the ethical guidelines for the 
investigation of experimental pain in 
conscious animals (Zimmerman et al., 1983), 
in accordance with the internationally 
accepted principles for laboratory animal use 




The plant material was collected from 
the local market, identified and authenticated 
taxonomically at National Scientific Institute, 
kingdom of Morocco. A voucher specimen of 
the collected sample was deposited in the 
institutional herbarium for future reference. 
 
Chemical constituents  
The content of saponins was evaluated 
by the determination of the foam index of 
plant extract. It was lower than 0.5 cm. The 




extraction of the flavonoïds was made in a 
methanolic solution according to the method 
described by Upson et al. (2000) with 
modifications. Some chips of magnesium 
were added to methanolic solution. Then, 5-6 
drops d'hydrochloric acid concentrate were 
added. The appearance of a red coloring 
indicated the presence of the flavonoïds and 
the orange color indicated the presence of 
flavones (Siddiqui et al., 1997). The presence 
of alkaloids in the methanolic extract was 
tested by the reagent of Dragendorff. The 
alkaloids appear in visible light in the form of 
orange spots (Merck et al., 1975). The extract 
was also analyzed by CCM on silica gel. The 
research of the sterol substances was made by 
the reaction of Lieberman-Burchard. Their 
presence gives a red-brown coloring 
transferring to brown-purplish. The presence 
of free quinonoids was confirmed by the 
method described by Ribéreau-Gayon (1968) 
and the presence of tannins by the method 
described by Rirk (1975). 
The appearance of fluorescence yellow, 
green, blue, orange after pulverization with 
KOH (10%) and visualization under UV with 
366 Nm, indicates the presence of coumarins 
(Ladiguina et al., 1990). 
 
Determination of DPPH scavenging activity 
DPPH radical scavenging activity of the 
extract was determined according to the 
classical method with slight modifications. An 
aliquot of 0.5 ml of sample solution in 
methanol was mixed with 2.5 ml of 0.5 mM 
methanolic solution of DPPH. The mixture 
was shaken vigorously and incubated for 37 
min in the dark at room temperature. The 
absorbance was measured at 517 nm using 
UV-vis spectrophotometer. Butyl Hydroxy 
Toluène (BHT) was used as a positive control. 
DPPH free radical scavenging ability (%) was 
calculated by using the formula:   [A517 nm 
of control – A517 nm of sample / A517 nm of 
control] x 100. 
 
Preparation of the aqueous extract of 
Thymelaea hirsuta 
T.  hirsuta  aerial  parts  were  prepared  
according  to  the  traditional method used  in 
Morocco  (decoction): 50 g powdered of  the 
whole plant mixed  with  500 ml  of  distilled  
water  was  boiled  for  15  min followed by 
cooling for 15 min. Thereafter, the aqueous 
extract was filtered and concentrated in rotary 
vacuum evaporator at a temperature below 50 
°C. The dried extracted material 
(approximately 10% w/w) was stored at -20 
°C until use. The aqueous extracts were 
prepared daily, just before administration, by 
dissolving it in distilled water.  
 
Evaluation of acute toxicity  
According to the Organization of 
Economic Co-operation and Development 
(OECD) guideline for testing of chemicals, 
TG420 (OECD, 2001a, 2003), rats were 
randomly divided into 2 groups per sex. The 
extract at a single dose of 5 mg/kg body 
weight was given orally to treated group (1st 
group), whereas an equal volume of water 
vehicle was given to control group (2nd 
group). Observations were made and recorded 
systematically 1, 2, 4 and 6 h after test 
substance administration. The visual 
observations included changes in the skin and 
fur, eyes and mucous membranes, and also 
respiratory, circulatory, autonomic and central 
nervous system as well as somatomotor 
activity and behavioral pattern. The number of 
survivors was noted after 24 h and these were 
then maintained for a further 14 days with a 
once daily observation. On the day 15, all rats 
were fasted for 16–18 h, then anesthetized 
with ethyl ether and sacrificed. 
 
Toxicological evaluation of the aqueous 
extract of Thymelaea hirsuta 
Rats were randomly divided into 4 
groups containing five animals per group and 
placed in separate cages during the study. The 
aqueous extract was given by gavages (4 
ml/kg) to different groups of rats daily at a 
dose of 0.0 g/kg, 0.5 g/kg, 1 g/kg or 2 g/kg 
body weight for 4 weeks. The control group 
received the vehicle only. The general 
behavior of rats and signs of toxicity were 
observed continuously for 1 h after the oral 




treatment, and then intermittently during 4 h, 
and thereafter over a period of 24 h (Twaij 
and al, 1983). The body weight changes were 
recorded every 15 days (T= 0, T= 15 and T= 
30 days). At the end of the 4 weeks period, 
blood was collected in two tubes from all rats 
after the animals were fasted overnight, 
anesthetized with diethyl ether and sacrificed 
by decapitation: one with the anticoagulant, 
ethylene-diamine–tetra-acetate (EDTA), and 
the other without any additive. The serum was 
prepared by centrifugation (3000 x g, 10 min, 
at +4 °C) to measure the biochemical 
parameters.  
 
Measurement of biochemical and 
hematological parameters  
Serum was analyzed for glucose, 
creatinine, blood urea nitrogen concentrations, 
for the activity of liver enzymes: alanine 
aminotransferase (ALAT) and aspartate 
aminotransferase (ASAT). They were 
determined enzymatically by standard 
methods with a biochemical automat (Konelab 
20 Thermo). The anticoagulated blood was 
analyzed immediately for hematological 
parameters: hemoglobin (Hb) concentration, 
hematocrit (Ht), mean corpuscular volume 
(MCV), mean corpuscular hemoglobin 
(MCH), mean corpuscular hemoglobin 
concentration (MCHC), erythrocytes (RBC), 
white blood cells (WBC), WBC differential 
count, and platelets. 
Hematological examination was 
performed using a KX21 automatic 
Haematology analyzer (Sysmex). For 
measurement of differential leukocytes, 
aliquots of whole blood samples were fixed on 
slide and analysed under microscope. 
 
Histopathological examination of the liver, 
kidney and spleen tissues 
After blood collection, the liver, kidneys 
and spleen were carefully dissected out. Small 
slices of these freshly harvested tissues were 
fixed in buffered formaldehyde solution 
(10%), dehydrated by serial ethanol solution, 
diaphanized with ethanol–benzene and 
enclosed with paraffin. Micrometer sections, 
cut by a microtome, were stained with 
hematoxylin–eosin and examined under a 
light microscope. 
 
In vivo hepatoprotective activity 
Animal treatment and preparation of test 
Hepatic injury was induced in rats by 
oral administration of 1 ml/kg CCl4 mixed 
with equal volume of olive oil every 72 h 
during 15 days. 
Rats were divided into three groups (n = 
5). Group I (normal control) was treated with 
vehicle (olive oil 1 ml/kg) daily for 15 days. 
Group II (CCl4 control) received 1 ml/kg CCl4 
mixed with equal volume of olive oil every 72 
h during 15 days. Group III (test group) 
received simultaneously the extract (1 g/kg) 
daily and CCl4 every 72 h for 15 days. 
Animals were sacrificed 48 after CCl4 
administration, blood sample of each animal 
was collected and serum was separated and 
used for estimation of ASAT and ALAT. 
Enzyme assays 
The enzymes ASAT, ALAT, were 
determined enzymatically by standard 




The differences among experimental 
and control groups were determined using the 
statistical software Graph Pad Prism Ver. 4.0 
for Windows XP. Comparisons among 
different groups were performed by analysis 
of variance using ANOVA test. Significant 
difference between control and experimental 
groups were assessed by student’s t- est. All 
data are expressed as mean ± standard error of 
measurement (S.E.M.); P-values less than 




From analysis, we confirmed that the 
aqueous extract of T. Hirsuta collected in 
Morroco was also rich in flavonoids, 
alkaloids, sterols, caumaris and tannins, and 
there was no saponins and free quinonoids 
(Table 1) like described in other studies 




(Djeridane et al., 2005; Dohou et al., 2004; El-




DPPH is a free radical and accepts an 
electron or hydrogen radical to become a 
stable diamagnetic molecule (Soares et al., 
1997). The reduction capability of DPPH 
radical was determined by the decrease in 
absorbance induced by plant antioxidants. 
BHT was used as standard. 
The extract has a stronger effect of 
scavenging free radical (80%) than positive 
control BHT (60%). 
It has been found that antioxidant 
molecules such as ascorbic acid, tocopherol, 
flavonoids, and tannins reduce and 
decolourize DPPH due to their hydrogen 
donating ability (Soares et al., 1997). 
Thymelea hirsuta extract is rich in phenolics 
which are involved in several biological 
activities including antioxidant ones. 
 
Effect of acute and sub-acute oral 
administration of Thymelea hirsuta extract 
on the body weight and mortality 
There were no deaths or any signs of 
toxicity observed after oral administration of a 
single dose of the aqueous extract (5 g/kg 
body weight) in the 14 days of observation.  
In the sub-acute toxicity study, the 
extract at doses of 0,5 g/kg, 1 g/kg, and 2 g/kg 
caused neither visible signs of toxicity nor 
mortality. Generally, the reduction in body 
weight gain and internal organ weights is a 
simple and sensitive index of toxicity after 
exposure to substance (Teo et al., 2002). 
Furthermore, gross examination of internal 
organs of all rats revealed no detectable 
abnormalities. Daily oral administration of T.
hirsuta aqueous extract for 30 days did not 
produce any obvious symptoms of toxicity or 
mortality up to the highest dose level used of 
2 g/kg. 
The body weights of control and 
aqueous extract-treated rats are presented in 
Figure 1. No significant difference in body 
weight changes was noted between the control 
group and any of treated groups at any time 
period. 
 
Effect of sub-chronic treatment of rats with 
Thymelaea hirsuta extract on the 
biochemical and hematological parameters 
The effect of sub-chronic treatment of 
rats with Thymelaea hirsuta extract on the 
biochemical parameters is presented in Figure 
2. Serum glucose, creatinine and urea levels of 
all rats treated with any dose of T. hirsuta 
extract (0.5-2 g/Kg) showed no variation 
compared to the control group. However, the 
serum levels of ALAT and ASAT were 
markedly and significantly decreased (P < 
0.05 and P<0.001 respectively) as compared 
to the controls (Figure 2). Treated rats did not 
show significant difference in red blood cells 
count (p<0.05), in Hemoglobin and 
Hematocrit serum levels but presented a 
significant increase in white blood cells count 
(p< 0.05) and in platelets for all doses tested 
(p<0.001) (Figure 3, Panels F and M 
respectively). Red blood cell indices (MCV, 
MCH, and CCMH) are indicated in Figure 3 
in Panels J, K, and L. There were no 
significant changes in these red blood cell 




Histopathological examination of the 
liver, spleen and kidneys (Figure 4) at the end 
of the study showed normal architecture 
suggesting no morphological disturbances rats 
treated with all doses of the T. hirsuta extract 
tested as compared to controls. 
 
Effect of Thymelaea hirsuta extract on 
ASAT and ALAT levels 
The results of the hepatoprotective 
effect of the extract are summarized in Table 
2. In comparison with normal group, there 
were significant increases both in the levels of 
ASAT and ALAT in CCl4- intoxicated rats, 
reflecting the liver injury by CCl4. The 
elevated levels of serum ASAT and ALAT 
were significantly reduced in the animals 
groups treated with the herbal extract.  
The histological observations basically 
support the results obtained from serum 
enzyme assays. Histology of the liver sections 
of normal control animals (Group I) showed 




normal hepatic cells with well preserved 
cytoplasm, prominent nucleus and nucleolus 
and well brought out central vein (Figure 4-A-
1). The liver sections of CCl4-intoxicated rats 
(Group II) showed massive fatty changes, 
necrosis, ballooning degeneration, and broad 
infiltration of the lymphocytes, histiocytes and 
Kuppfer cells around the central vein and the 
loss of cellular boundaries (Figure 5-A). The 
histological architecture of liver sections of 
rats treated with extract 1g/kg (Group III) 
showed a more or less normal lobular pattern 
with a mild degree of fatty change, without 
necrosis and lymphocyte infiltration almost 
comparable to the normal control (Figure 5-
B).
  













                Table 2: Effect of Thymelaea hirsuta extract on ASAT and ALAT serum levels. 
 
Groups      Treatments ALAT (U/l) ASAT (U/l) 
      I            Normal (olive oil)    79.5 ±10a   86.0 ±  2 
     II            CCl4 control  101.0 ±15 113.0 ±12 
    III            Extract + CCl4    63.0 ±13   87.5 ±  5 




Figure 1: Body weight gain curves of Wistar rats treated orally with aqueous extract of Thymelaea 
hirsuta (Th) (0.5 g/kg, 1 g/kg, 2 g/kg) for 4 weeks. The values are expressed as mean ± S.E.M. (n = 
5 rats/group). 








           
 
 
      
 Figure 2: Effect of oral administration of Thymelaea hirsuta extract on biochemical parameters. 
The aqueous extract of the plant was given daily by the oral route to groups of Wistar rats (n =5 per group) at the following 
doses: 0g/kg, 0.5 g/kg, 1g/kg and 2 g/kg for 30 days. Data are expressed as mean ± S.E.M.; (*) P <0.05; (**) P <0.01 versus 
the control group. (ALAT:  Alanine aminotransferase; ASAT: Aspartate aminotransferase).  
 
 




   
 
    
 
            




        
        





Figure 3: Effect of oral administration of Thymelaea hirsuta extract on hematological parameters of 
rats (MCV; mean corpuscular volume; MCH: mean corpuscular haemoglobin; MCHC: Mean 
corpuscular hemoglobin concentration). 
 The aqueous extract of the plant was given daily by the oral route to groups of Wistar rats (n =5 per group) at the following 
doses: 0g/kg, 0.5 g/kg, 1g/kg and 2g/kg, for 30 days. Data are expressed as mean ± S.E.M.; (*) P <0.05; (**) P <0.01 versus 
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Figure 4: Histological observation of liver, kidney and spleen tissues after sub-chronic treatment 
with the Thymelaea hirsuta extract. 
(A) Liver sections of normal control rats (1), rats treated with 1 g/kg (2) and 2 g/kg (3) of extract for 30 days showing 
normal hepatic cells with well-preserved cytoplasm; well brought out central vein; prominent nucleus and nucleolus. 
(B) Kidney section of normal control rats (1), rats treated with 1 g/kg (2) and 2 g/kg (3) of extract showing a normal 
architecture of the tissue.  
(C) Spleen section of normal control rats (1), rats treated with 1 g/kg (2) and 2 g/kg (3) of extract showing a normal 
architecture of the tissue. 
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Figure 5. Histopathological changes in CCl4 intoxicated and Thymelaea hirsuta treated rats. 
(A) Group II: Liver section of CCl4 treated rats. (1) Cholestase with biliary intracytoplasmic inclusions (HE 
x100). (2) And (3) Massive fatty changes, necrosis, ballooning degeneration, and broad infiltration of the lymphocytes 
around the central vein (HE x40).  
(B) Group III: Liver section of CCl4 and extract treated rats. (1) And (2) normal lobular pattern with a mild degree of fatty 





To determine the safety of drugs and 
plant products for human use, toxicological 
evaluation is carried out in various 
experimental animals to predict toxicity and to 
provide guidelines for selecting a ‘safe’ dose 
in humans. The concordance of toxicity in 
animals with humans is with hematological, 
gastrointestinal and cardiovascular adverse 
effects (Olson et al., 2000).  
Furthermore, it is quite difficult to 
ascertain certain adverse effects in animals 
such as headache, pain and visual 
disturbances. In addition, inter species 
differences in the pharmacokinetic parameters 
make it difficult to translate some adverse 
effects from animals to humans. Toxicity tests 
are essentially performed on either mice or 
rats because of their availability, low cost and 
the wealth of toxicology data in the literature 
already available for these species (Rollo, 
2004). 
The evaluation of adverse effects of 
sub-chronic and chronic dosing in 
experimental animals may be more relevant in 
determining the overall toxicity of the plant 
preparation. Acute toxicity studies with 
arrange of doses have to be conducted first to 
select proper dose(s). The present 
investigation shows that an aqueous extract of 
the aerial parts of T. hirsuta at the dose of 5 
g/kg given by oral route doesn’t have any 
effect of toxicity.  




For chronic and sub-chronic studies; the 
doses selected for chronic and sub-chronic 
toxicity studies should be at and above the 
suggested human dose. Daily oral 
administration of T. hirsuta aqueous extract 
for 30 days did not produce any obvious 
symptoms of toxicity or mortality up to the 
highest dose level of 2 g/kg. There was also 
no change in animal behavior, and the body 
weight gains were not significantly different 
in the treated rats as compared to the controls. 
Since, changes in body weight have been used 
as an indicator of adverse effects of drugs and 
chemicals (Teo et al., 2002), the present 
results suggest that at the oral doses 
administered of the T. hirsuta-extract is non-
toxic in rats. 
Because kidney and liver toxicity has 
been reported following the use of 
phytotherapeutic products (Saad et al., 2006), 
biochemical parameters evaluation is 
important. In the present study, creatinine and 
urea determinations were critical as markers 
of kidney activity (Newman et al., 
1999).There were no significant differences of 
glucose, creatinine and urea levels in the 
groups treated with the herbal extract. This 
was also being confirmed by the absence of 
histopathological changes in the kidney 
tissues. At the dose tested T. hirsuta extract 
doesn’t acts as hypoglycemic product as 
reported in others studies (Bnouham et al., 
2007) under these experimental conditions. 
Among the parameters evaluated, ASAT 
and ALAT are considered markers for liver 
function (Hilaly et al., 2004). In the present 
study, there were significant decreases in 
ASAT and ALAT values. ALAT is located 
primarily in the cytosol of hepatocytes, and 
this enzyme is considered a more sensitive 
marker of hepatocellular damage than ASAT. 
ASAT is an enzyme found in the cytoplasm 
and mitochondria in different tissues, chiefly 
in the heart and skeletal muscles, liver, 
kidneys, pancreas, and erythrocytes (Chaves 
et al., 1998). The decrease of these two 
enzymes values suggested a hepatoprotective 
action of the aqueous extract of T. hirsuta. So 
we tested the effect of daily oral 
administration of the T. hirsuta -extract in 
CCl4-intoxicated rats. In fact, the elevated 
levels of serum ASAT and ALAT in CCl4-
intoxicated rats were significantly reduced in 
the animals groups treated with herbal extract. 
Thus it suggests that the T. hirsuta -extract 
have a hepatoprotective effect against liver 
injury confirmed by histopathological 
examination of liver tissue. The present study 
showed for the first time, that aqueous extract 
from T. hirsuta possess hepatoprotective 
activity as evidenced by the significant 
inhibition in the elevated levels of serum 
enzyme activities induced by CCl4. CCl4 is 
bio-transformed by the cytochrome P450 
system in the endoplasmic reticulum to 
produce trichloromethyl free radical (•CCl3). 
Trichloromethyl free radical then combined 
with cellular lipids and proteins in the 
presence of oxygen to form a trichloromethyl 
peroxyl radical, which may attack lipids on 
the membrane of endoplasmic reticulum faster 
than trichloromethyl free radical. Thus, 
trichloromethylperoxyl free radical leads to 
elicit lipid peroxidation, the destruction of 
Ca2+ homeostasis, and finally, results in cell 
death (Reckengel et al., 1989). These result in 
changes of structures of the endoplasmic 
reticulum and other membrane, loss of 
enzyme metabolic enzyme activation, 
reduction of protein synthesis and loss of 
glucose-6-phosphatase activation, leading to 
liver damage (Azri et al., 1992; Wong et al., 
2011). In this view, the reduction in levels of 
ASAT and ALAT by the extracts is an 
indication of stabilization of plasma 
membrane as well as repair of hepatic tissue 
damage caused by CCl4. This effect is 
agreement with the commonly accepted view 
that serum levels of transaminases return to 
normal with the healing of hepatic 
parenchyma and regeneration of hepatocytes 
(Thabrew et al., 1987; Wong et al., 2011).  
Since the preliminary phytochemical 
analysis of the extracts have shown the 
presence of flavonoids and phenolic 
compounds, which have been known for its 




antioxidant and hepatoprotective activities 
(Djeridane et al., 2005), thus it can be 
concluded that possible mechanism of 
hepatoprotective activity of T. hirsuta may be 
due to its antioxidant activity, which may be 
due to the presence of flavonoids and phenolic 
compounds in the extracts.  
Data have shown that hepatic damage 
induced by CCl4 is mediated by depleting 
oxygen radical scavengers in the hepatocytes; 
free radical metabolites, generated from 
bioactivation, which interact with unsaturated 
lipid membrane to cause lipid peroxidation 
and other cellular macromolecules leading to 
cell damage (Wong et al., 2011).  In this 
study, the CCl4 produced significant 
reductions in the activity of catalase, SOD, 
peroxidase and GSH and T. hirsuta-extract 
significantly increased CCl4-diminshed 
hepatic SOD, catalase, peroxidase and GSH 
activities (data not shown).  
The preservation and induction of the 
activity of in vivo antioxidant enzymes 
suggest that the aqueous extract of T. hirsuta 
promotes the scavenging of reactive free 
radicals thus protecting the histostructural 
integrity of the liver cells.  
Analysis of blood parameters is relevant 
to risk evaluation as the changes in the 
hematological system have a higher predictive 
value for human toxicity, when the data are 
translated from animal studies (Olson et al., 
2000). In the present study, with the exception 
of a significant increase in white blood cells 
count and in platelets for all doses tested, 
there were no significant alterations in the 
others hematological parameters of rats. These 
results can suggest an immune-stimulatory 




The studies carried out suggest that at 
all the oral doses tested, Thymelaea hirsuta 
can be considered safe as it did not cause 
either any lethality or adverse changes in the 
general behavior, histological or 
hematological and biochemical parameters in 
the acute and in sub-chronic toxicity studies in 
rats. Further studies in non-rodents must be 
performed to prove its safety. The results of 
this study strongly indicate that T. hirsuta has 
a potent hepatoprotective action against 
carbon tetrachloride induced hepatic damage 
in rats related to glutathione mediated 
detoxification as well free radical scavenging 
activity. Further studies are in progress for 
better understanding of the mechanism of 
action and to evaluate the efficacy of T. 
hirsuta on liver organelle that are possibly 
damaged during experimental hepatitis. 
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